News ImmuCell Corporation

Stocks

ICCC

US4525253062

Pharmaceuticals

Delayed Nasdaq 07:18:22 29/10/2026 pm IST			5-day change	1st Jan Change
10.28 ^USD	-3.20%		-1.53%	+67.15%

13/10	ImmuCell Q3 Preliminary Sales Rise	MT
13/10	Immucell Corporation Reports Preliminary Unaudited Sales Results for the Third Quarter and Nine Months Ended September 30, 2026	CI

All News

Mentions Relevance

13/10	ImmuCell Q3 Preliminary Sales Rise	MT
13/10	Immucell Corporation Reports Preliminary Unaudited Sales Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
14/08	ImmuCell Corporation, Q2 2026 Earnings Call, Aug 14, 2026
14/08	ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
14/08	ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026	AQ
07/08	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026	AQ
10/07	Immucell Corporation Reports Preliminary Unaudited Sales Results for the Second Quarter and Six Months Ended June 30, 2026	CI
10/07	ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results	AQ
15/05	ImmuCell Corporation, Q1 2026 Earnings Call, May 15, 2026
15/05	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026	AQ
15/05	ImmuCell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
09/05	ImmuCell, Norbrook enter settlement deed on May 8, 2026 - SEC filing	RE
08/05	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026	AQ
22/04	ImmuCell : Corporate Presentation (Investor Relations April 2026 Final)	PU
14/04	ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors	AQ
14/04	ImmuCell Corporation Announces Board Changes	CI
09/04	ImmuCell Q1 Sales Jump; Shares Rise After Hours	MT
09/04	ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results	AQ
09/04	Immucell Corporation Announces Preliminary, Unaudited Sales Results for the Firs Quarter of 2026	CI
19/03	Immucell Corporation Announces Changes to Its Board, Effective April 1, 2026	CI
19/03	ImmuCell : 03-18-26 – ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board	PU
19/03	ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board	AQ
06/03	ImmuCell Corporation, Q4 2025 Earnings Call, Mar 05, 2026
05/03	ImmuCell Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
05/03	ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025	AQ